ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 697730 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 697730; 2) Community: the network communities that were significantly associated with the response to NSC 697730; 3) Molecule: the relationships between components within communities and NSC 697730; 4) MDR: the compounds that were significantly associated with the NSC 697730.

NSC Compound Enrichment Correlation
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.00433056621075589 0.22013102
NSC 670329 Null 0.00433056621075589 0.1294117
NSC 698960 Null 0.00433056621075589 0.50678928
NSC 732336 [6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl]acetic acid 2-hydroxy-5-bromobenzylidenehydrazide 0.00433056621075589 0.29792979
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.00433056621075589 0.12927002
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.00433056621075589 0.28776089
NSC 92504 Null 0.00433056621075589 0.21019818
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.00567322425730611 0.042210076
NSC 114346 Null 0.00567322425730621 0.004471251
NSC 303861 L-Cysteine analog 0.00567322425730621 0.46198821
Total:67  Current:9    [First] [Prev] [Next] [Last]